# Recursion to Present at 44th Annual J.P. Morgan Healthcare Conference
Canonical URL: https://biopharmsignal.com/news/RXRX/recursion-to-present-at-44th-annual-j-p-morgan-healthcare-conference-a211ee4a
Ticker: RXRX
Company: Recursion
Source: Recursion
Published: 2026-01-06 12:59 EST
## Summary

Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically...

## Article Body
Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its CEO & President, Najat Khan, Ph.D., will present Tuesday, January 13, 10:30am PT at the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco.

Management will also participate in the following upcoming investor conference:

28th Annual Needham Growth Conference - Friday, January 16, 2026

Webcasts may be found in the events section of the Recursion Investor Relations website at ir.recursion.com . About Recursion Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine. Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New York, London, and the Oxford area. Learn more at www.recursion.com , or connect on X and LinkedIn .
## Recent Company News
- 2026-06-02 12:00 EST — [Recursion to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/RXRX/recursion-to-participate-in-upcoming-investor-conferences-f4e26896) — Source: Recursion
- 2026-05-29 20:30 EST — [Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules](https://biopharmsignal.com/news/RXRX/recursion-reports-grant-of-inducement-awards-as-permitted-by-the-nasdaq-listing--92e9e803) — Source: Recursion
- 2026-05-06 10:30 EST — [Recursion Reports First Quarter Financial Results and Provides Business Update](https://biopharmsignal.com/news/RXRX/recursion-reports-first-quarter-financial-results-and-provides-business-update-5395800d) — Source: Recursion
- 2026-04-30 20:30 EST — [Recursion Announces Board Transition](https://biopharmsignal.com/news/RXRX/recursion-announces-board-transition-f495c9f3) — Source: Recursion
- 2026-04-29 11:59 EST — [Recursion to Report First Quarter 2026 Business Updates and Financial Results on May 6](https://biopharmsignal.com/news/RXRX/recursion-to-report-first-quarter-2026-business-updates-and-financial-results-on-371275ef) — Source: Recursion
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)